ALKA-SELTZER GOLD

ALKA-SELTZER GOLD was reported 52 times

ALKA-SELTZER GOLD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GASTROSCHISIS 1 0.0021
1 CONGENITAL HYDRONEPHROSIS 1 0.0014
2 ALLERGIC COUGH 1 0.0013
3 CORTISOL DECREASED 1 0.0009
4 GROIN ABSCESS 1 0.0008
5 JAUNDICE NEONATAL 1 0.0005
6 INFUSION SITE BRUISING 1 0.0005
7 REACTION TO DRUG EXCIPIENTS 1 0.0005
8 ACCIDENT AT WORK 1 0.0005
9 DEVICE INFUSION ISSUE 1 0.0004
10 URINE ANALYSIS ABNORMAL 1 0.0003
11 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
12 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
13 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
14 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
15 PULSE ABSENT 1 0.0002
16 INCORRECT DOSAGE ADMINISTERED 1 0.0002
17 PRODUCT COLOUR ISSUE 1 0.0002
18 AUTISM SPECTRUM DISORDER 1 0.0002
19 HEART RATE ABNORMAL 1 0.0002
20 THERAPEUTIC RESPONSE CHANGED 1 0.0002
21 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
22 MULTIPLE ALLERGIES 1 0.0001
23 PRODUCT PACKAGING ISSUE 1 0.0001
24 GASTRIC ULCER 2 0.0001
25 EMPHYSEMA 1 0.0001
26 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
27 DRUG DEPENDENCE 14 0.0001
28 GASTRIC HAEMORRHAGE 1 0.0001
29 MENTAL IMPAIRMENT 2 0.0001
30 MUSCLE ATROPHY 1 0.0001
31 HAEMATEMESIS 2 0.0001
32 INFUSION SITE PAIN 1 0.0001
33 SEASONAL ALLERGY 1 0.0001
34 IMMUNODEFICIENCY 1 0.0001
35 BLOOD COUNT ABNORMAL 1 0.0001
36 VENTRICULAR TACHYCARDIA 1 0.0001
37 LEUKOCYTOSIS 1 0.0001
38 CONJUNCTIVITIS 1 0.0001
39 PULMONARY FIBROSIS 1 0.0001
40 CHOKING 1 0.0001
41 IMPAIRED WORK ABILITY 1 0.0000
42 POOR QUALITY SLEEP 1 0.0000
43 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
44 PRODUCT PRESCRIBING ISSUE 1 0.0000
45 CHROMATURIA 1 0.0000
46 THROAT TIGHTNESS 1 0.0000
47 MOOD ALTERED 1 0.0000
48 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
49 ANGINA PECTORIS 1 0.0000
50 HYPERSOMNIA 1 0.0000
51 PREMATURE BABY 1 0.0000
52 LACRIMATION INCREASED 1 0.0000
53 DRUG ADMINISTRATION ERROR 1 0.0000
54 PRODUCT DOSE OMISSION 2 0.0000
55 EYE PRURITUS 1 0.0000
56 HYPOXIA 1 0.0000
57 DRUG EFFECT INCOMPLETE 1 0.0000
58 UNDERDOSE 2 0.0000
59 THROAT IRRITATION 1 0.0000
60 SKIN DISCOLOURATION 1 0.0000
61 HYPOKALAEMIA 1 0.0000
62 PRODUCT USE ISSUE 4 0.0000
63 DISEASE RECURRENCE 1 0.0000
64 HYPOGLYCAEMIA 1 0.0000
65 MUSCULOSKELETAL PAIN 1 0.0000
66 FLATULENCE 1 0.0000
67 EYE IRRITATION 1 0.0000
68 BONE PAIN 1 0.0000
69 CATARACT 1 0.0000
70 FEELING HOT 1 0.0000
71 INFUSION RELATED REACTION 1 0.0000
72 HEPATIC ENZYME INCREASED 1 0.0000
73 INCORRECT DOSE ADMINISTERED 3 0.0000
74 DIABETES MELLITUS 1 0.0000
75 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
76 ABDOMINAL DISCOMFORT 2 0.0000
77 RENAL IMPAIRMENT 1 0.0000
78 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
79 COVID-19 2 0.0000
80 OROPHARYNGEAL PAIN 1 0.0000
81 HYPERSENSITIVITY 2 0.0000
82 NEUROPATHY PERIPHERAL 1 0.0000
83 CONTUSION 1 0.0000
84 DRUG INTOLERANCE 1 0.0000
85 ATRIAL FIBRILLATION 1 0.0000
86 DYSPEPSIA 1 0.0000
87 SINUSITIS 1 0.0000
88 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
89 HAEMORRHAGE 1 0.0000
90 HYPERTENSION 2 0.0000
91 INFLUENZA 1 0.0000
92 OEDEMA PERIPHERAL 1 0.0000
93 DRY SKIN 1 0.0000
94 PRODUCT QUALITY ISSUE 1 0.0000
95 PAIN IN EXTREMITY 2 0.0000
96 BLOOD PRESSURE INCREASED 1 0.0000
97 HEADACHE 4 0.0000
98 DEATH 5 0.0000
99 MYOCARDIAL INFARCTION 1 0.0000
100 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
101 MUSCLE SPASMS 1 0.0000
102 NASOPHARYNGITIS 1 0.0000
103 BLOOD GLUCOSE INCREASED 1 0.0000
104 ANAEMIA 1 0.0000
105 GAIT DISTURBANCE 1 0.0000
106 PRURITUS 2 0.0000
107 ABDOMINAL PAIN UPPER 1 0.0000
108 OVERDOSE 1 0.0000
109 FEELING ABNORMAL 1 0.0000
110 NAUSEA 3 0.0000
111 INSOMNIA 1 0.0000
112 ANXIETY 1 0.0000
113 OFF LABEL USE 3 0.0000
114 PRODUCT DOSE OMISSION ISSUE 1 0.0000
115 INJECTION SITE PAIN 1 0.0000
116 ASTHENIA 1 0.0000
117 FATIGUE 2 0.0000
118 ARTHRALGIA 1 0.0000
119 RASH 1 0.0000
120 MALAISE 1 0.0000
121 DIZZINESS 1 0.0000
122 DYSPNOEA 1 0.0000
123 DRUG INEFFECTIVE 1 0.0000